BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Daiichi Sankyo
Express Scripts
Mallinckrodt
Johnson and Johnson
Colorcon
Argus Health
Federal Trade Commission
Queensland Health

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,649,659

« Back to Dashboard

Which drugs does patent 6,649,659 protect, and when does it expire?

Patent 6,649,659 protects MEPRON and is included in one NDA.

Protection for MEPRON has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
Summary for Patent: 6,649,659
Title: Atovaquone pharmaceutical compositions
Abstract:The invention relates to a process for the production of microfluidized particles of atovaquone having improved bioavailability.
Inventor(s): Dearn; Alan Roy (Dartford, GB)
Assignee: SmithKline Beecham Corporation (Philadelphia, PA)
Application Number:09/411,381
Patent Claim Types:
see list of patent claims
Composition; Use;

Drugs Protected by US Patent 6,649,659

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Glaxosmithkline Llc MEPRON atovaquone SUSPENSION;ORAL 020500-001 Feb 8, 1995 AB RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,649,659

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9226905Dec 24, 1992

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Julphar
Novartis
Baxter
AstraZeneca
QuintilesIMS
McKesson
Cipla
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot